1. Home
  2. MDXH vs EPSM Comparison

MDXH vs EPSM Comparison

Compare MDXH & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • EPSM
  • Stock Information
  • Founded
  • MDXH 2003
  • EPSM 2010
  • Country
  • MDXH Belgium
  • EPSM China
  • Employees
  • MDXH N/A
  • EPSM N/A
  • Industry
  • MDXH
  • EPSM
  • Sector
  • MDXH
  • EPSM
  • Exchange
  • MDXH Nasdaq
  • EPSM Nasdaq
  • Market Cap
  • MDXH 203.4M
  • EPSM 178.3M
  • IPO Year
  • MDXH 2021
  • EPSM 2025
  • Fundamental
  • Price
  • MDXH $3.28
  • EPSM $3.64
  • Analyst Decision
  • MDXH Strong Buy
  • EPSM
  • Analyst Count
  • MDXH 3
  • EPSM 0
  • Target Price
  • MDXH $7.67
  • EPSM N/A
  • AVG Volume (30 Days)
  • MDXH 333.0K
  • EPSM 3.0M
  • Earning Date
  • MDXH 11-12-2025
  • EPSM 12-16-2025
  • Dividend Yield
  • MDXH N/A
  • EPSM N/A
  • EPS Growth
  • MDXH N/A
  • EPSM N/A
  • EPS
  • MDXH N/A
  • EPSM 0.02
  • Revenue
  • MDXH $103,069,000.00
  • EPSM $12,518,070.00
  • Revenue This Year
  • MDXH $24.78
  • EPSM N/A
  • Revenue Next Year
  • MDXH $21.20
  • EPSM N/A
  • P/E Ratio
  • MDXH N/A
  • EPSM $96.06
  • Revenue Growth
  • MDXH 21.68
  • EPSM N/A
  • 52 Week Low
  • MDXH $1.35
  • EPSM $1.31
  • 52 Week High
  • MDXH $5.33
  • EPSM $155.00
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.74
  • EPSM N/A
  • Support Level
  • MDXH $2.75
  • EPSM N/A
  • Resistance Level
  • MDXH $4.98
  • EPSM N/A
  • Average True Range (ATR)
  • MDXH 0.28
  • EPSM 0.00
  • MACD
  • MDXH -0.17
  • EPSM 0.00
  • Stochastic Oscillator
  • MDXH 23.45
  • EPSM 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.

Share on Social Networks: